Nicolas Collongues Selected Research

Nicolas Collongues Research Topics

Disease

16	Neuromyelitis Optica (Devic's Disease) 01/2022 - 10/2012
15	Multiple Sclerosis 09/2022 - 01/2014
4	Relapsing-Remitting Multiple Sclerosis 06/2022 - 03/2015
4	COVID-19 10/2021 - 01/2020
4	Inflammation (Inflammations) 06/2020 - 10/2012
3	Myelitis 01/2022 - 08/2012
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2020 - 12/2017
3	Demyelinating Diseases (Demyelinating Disease) 06/2020 - 03/2015
3	Transverse Myelitis (Necrotizing Myelitis) 04/2020 - 10/2013
2	Disease Progression 09/2022 - 04/2020
2	Reinfection 09/2021 - 01/2021
2	Neuroinflammatory Diseases 06/2021 - 10/2012
2	Necrosis 06/2021 - 08/2013
2	Optic Neuritis (Retrobulbar Neuritis) 05/2016 - 10/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 01/2013
1	Pain (Aches) 01/2022
1	Susac Syndrome 01/2022
1	Obesity 10/2021
1	Sarcoidosis (Schaumann Disease) 06/2021
1	Spontaneous Abortion (Miscarriage) 01/2021
1	Fatigue 06/2020
1	Atrophy 06/2020
1	Infections 01/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2019
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 05/2017
1	Chronic Progressive Multiple Sclerosis 01/2017
1	Seizures (Absence Seizure) 07/2016
1	Epilepsy (Aura) 07/2016
1	Generalized Epilepsy 07/2016
1	Vomiting 05/2016
1	Hiccup (Hiccups) 05/2016
1	Paraplegia (Spastic Paraplegia) 05/2015
1	Hereditary Spastic Paraplegia 05/2015
1	Amnesia (Dissociative Amnesia) 08/2013
1	Stroke (Strokes) 08/2013
1	Progressive Multifocal Leukoencephalopathy 11/2012
1	CADASIL 08/2012
1	Vasculitis (Vasculitides) 03/2011

Drug/Important Bio-Agent (IBA)

11	AntibodiesIBA 01/2022 - 03/2011
7	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 03/2015
6	Immunoglobulin G (IgG)IBA 01/2022 - 10/2012
4	Natalizumab (Tysabri)FDA Link 06/2022 - 11/2012
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2012
3	Immunosuppressive Agents (Immunosuppressants)IBA 10/2021 - 07/2019
2	Pharmaceutical PreparationsIBA 09/2022 - 01/2021
2	Fingolimod Hydrochloride (FTY720)FDA Link 06/2022 - 01/2021
2	ocrelizumabIBA 06/2022 - 01/2019
2	Oligoclonal BandsIBA 01/2022 - 08/2012
2	AutoantibodiesIBA 01/2022 - 01/2013
2	Rituximab (Mabthera)FDA Link 01/2022 - 05/2016
2	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2022
2	Aquaporin 4IBA 01/2022 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 12/2017
2	nitazoxanide (NTZ)FDA Link 01/2021 - 01/2014
2	Biotin (Vitamin H)FDA Link 01/2021 - 08/2019
2	Monoclonal AntibodiesIBA 01/2021 - 05/2017
2	Testosterone (Sustanon)FDA Link 06/2020 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2019 - 01/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022
1	Infliximab (Remicade)FDA Link 01/2022
1	Nucleocapsid ProteinsIBA 09/2021
1	VaccinesIBA 09/2021
1	SteroidsIBA 06/2021
1	anti-aquaporin 4 autoantibodyIBA 01/2021
1	Aquaporins (Water Channels)IBA 04/2020
1	Biological ProductsIBA 04/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 07/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2019
1	satralizumabIBA 02/2019
1	eculizumab FDA Link 02/2019
1	Therapeutic UsesIBA 02/2019
1	Estrogens (Estrogen)FDA Link 01/2018
1	N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 12/2017
1	LigandsIBA 12/2017
1	Myelin Basic ProteinIBA 12/2017
1	Messenger RNA (mRNA)IBA 12/2017
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2017
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2017
1	SolutionsIBA 05/2017
1	Methylprednisolone FDA LinkGeneric 01/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2016
1	pitolisantIBA 07/2016
1	4-Aminopyridine (4 Aminopyridine)FDA Link 05/2015
1	sperm releasing substanceIBA 05/2015
1	Heroin (Diamorphine)IBA 08/2013
1	AutoantigensIBA 01/2013
1	GadoliniumIBA 08/2012

Therapy/Procedure

8	Therapeutics 02/2021 - 11/2012
3	Immunotherapy 09/2022 - 01/2022
1	Artificial Respiration (Mechanical Ventilation) 10/2021
1	Investigational Therapies (Experimental Therapy) 06/2020
1	Drug Therapy (Chemotherapy) 02/2019
1	Biological Therapy 05/2017
1	Plasma Exchange 05/2017
1	Aftercare (After-Treatment) 05/2015